The report is available in English with a French summary - KCE
The report is available in English with a French summary - KCE
The report is available in English with a French summary - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
226 Musculoskeletal & Neurological Rehabilitation <strong>KCE</strong> <strong>report</strong>s 57<br />
Rommers 237 found an <strong>in</strong>cidence of LEA <strong>in</strong> the Netherlands of 19/100.000. He also states<br />
that about half of the patients are fitted <strong>with</strong> a prosthes<strong>is</strong> 66 . Based on other literature<br />
data as described <strong>in</strong> chapter 2 and on data of the RIZIV/INAMI we estimate the<br />
<strong>in</strong>cidence <strong>in</strong> Belgium somewhat lower. (RIZIV/INAMI data: number of AK amputations<br />
<strong>in</strong> 1995: 653, <strong>in</strong> 1998: 614; BK amputations <strong>in</strong> 1995: 448, <strong>in</strong> 1998: 489; number of<br />
evaluation prostheses for BK provided <strong>in</strong> 2005 and 2006: 272 and 303; number of<br />
evaluation prostheses for AK provided <strong>in</strong> 2005 and 2006: 213 and 282). Comb<strong>in</strong><strong>in</strong>g<br />
these data, the number of LEA for Belgium <strong>is</strong> estimated at 1200/year. About 50% of the<br />
patients are fitted <strong>with</strong> a prosthes<strong>is</strong>, almost as much for AK as for BK. Th<strong>is</strong> means 300<br />
patients for subgroup 1 as well as for subgroup 2, when patients deserv<strong>in</strong>g a prosthes<strong>is</strong><br />
are taken <strong>in</strong>to account for post-acute multid<strong>is</strong>cipl<strong>in</strong>ary rehabilitation, and patients<br />
<strong>with</strong>out prosthes<strong>is</strong> are assumed to follow monod<strong>is</strong>cipl<strong>in</strong>ary treatment.<br />
<strong>The</strong> estimated <strong>in</strong>cidence of SCI <strong>in</strong> Belgium based on literature (chapter 2) <strong>is</strong> between 1<br />
and 3/100000. Th<strong>is</strong> seems to be confirmed by a newsletter of ISCoS (International<br />
Sp<strong>in</strong>al Cord Society) <strong>in</strong> December 2006. A European survey was performed, us<strong>in</strong>g a<br />
questionnaire that was sent to experts <strong>in</strong> 21 European countries. <strong>The</strong> results showed a<br />
mean <strong>in</strong>cidence of SCI of 1,75/100000. So we estimate the number of new cases <strong>in</strong><br />
Belgium at 200/year, 100 paraplegics and 100 tetraplegics.<br />
For MS the number of new cases <strong>in</strong> Belgium yearly <strong>is</strong> estimated at 400. <strong>The</strong> prevalence<br />
<strong>in</strong> Belgium, which <strong>in</strong> th<strong>is</strong> case <strong>is</strong> relevant as it concerns a progressive d<strong>is</strong>order, <strong>is</strong><br />
estimated at 10 000 (see chapter 2). Based on Belgian expert op<strong>in</strong>ion, it <strong>is</strong> assumed that<br />
+15% of the patients need cont<strong>in</strong>uous ambulatory rehabilitation, which means 1500<br />
patients. Based on <strong>in</strong>formation of the FOD/SPF Volksgezondheid, Santé Publique<br />
(Technical Cell), it was estimated that each year 10% of the MS patients need<br />
hospitalization. <strong>The</strong>se numvers are <strong>in</strong> l<strong>in</strong>e <strong>with</strong> the Flem<strong>is</strong>h study publ<strong>is</strong>hed <strong>in</strong> 1998 by<br />
Carton et al 240 .<br />
Concern<strong>in</strong>g stroke we estimate the number of new patients at 19 000/year (see chapter<br />
2). Accord<strong>in</strong>g to the gold f<strong>is</strong>t rule of Fortune and Wenn 238 , approximately 1/3 dies, 1/3<br />
recovers and 1/3 presents <strong>with</strong> permanent d<strong>is</strong>ability. Of these patients only half <strong>is</strong><br />
younger than 75 years and even less are younger than 70 years. Part of these patients<br />
goes directly to a nurs<strong>in</strong>g home and part of them can be treated <strong>in</strong> a geriatric ward. So<br />
it <strong>is</strong> assumed that only about 15% of all stroke patients need post-acute rehabilitation<br />
services, which br<strong>in</strong>gs us to 2860 patients yearly. Th<strong>is</strong> assumption was confirmed by the<br />
real data of a Belgian expert centre (Stroke Unit d<strong>is</strong>charge).<br />
Especially for ambulatory rehabilitation, the percentages of patients need<strong>in</strong>g<br />
multid<strong>is</strong>cipl<strong>in</strong>ary rehabilitation are highly uncerta<strong>in</strong>. To account for th<strong>is</strong> uncerta<strong>in</strong>ty, a<br />
beta d<strong>is</strong>tribution was applied to each of these percentages. Th<strong>is</strong> <strong>is</strong> the accepted<br />
d<strong>is</strong>tribution for uncerta<strong>in</strong> proportions. <strong>The</strong> upper and lower limits are essentially<br />
arbitrary, as there are no data <strong>in</strong> literature or from centres that can provide a clue to<br />
the ranges. <strong>The</strong> lower limit was therefore arbitrarily set at a rehabilitation need of 50%<br />
of the po<strong>in</strong>t estimate and the upper limit at 130% of the po<strong>in</strong>t estimate. <strong>The</strong> po<strong>in</strong>t<br />
estimate itself was def<strong>in</strong>ed as the mean of the beta d<strong>is</strong>tribution.<br />
Dur<strong>in</strong>g the Monte Carlo simulation of the costs, revenues and expenditures for Belgium<br />
as a whole, values are chosen at random from these d<strong>is</strong>tributions. Th<strong>is</strong> eventually leads<br />
to total cost, revenue and expenditure estimates <strong>with</strong> a probabil<strong>is</strong>tic d<strong>is</strong>tribution. 95%<br />
confidence <strong>in</strong>tervals were constructed around the po<strong>in</strong>t estimates based on the Monte<br />
Carlo simulations. <strong>The</strong> analyses were performed <strong>in</strong> @r<strong>is</strong>k version 4.5.5.<br />
Because these five pathologies obviously do not cover the entire population <strong>in</strong> need of<br />
multid<strong>is</strong>cipl<strong>in</strong>ary rehabilitation, it was assumed <strong>in</strong> the extrapolation that these five<br />
pathologies cover about 75% of the total hospitalization costs and 60% of the total<br />
ambulatory care costs for multid<strong>is</strong>cipl<strong>in</strong>ary rehabilitation. Th<strong>is</strong> <strong>is</strong> cons<strong>is</strong>tent <strong>with</strong> the<br />
figures <strong>in</strong> chapter 2 for hospital rehabilitation and <strong>with</strong> the <strong>report</strong>ed case-mix of two<br />
non-university rehabilitation centres <strong>in</strong> Belgium. To account for the uncerta<strong>in</strong>ty<br />
associated <strong>with</strong> th<strong>is</strong> 60%, a beta d<strong>is</strong>tribution was applied to th<strong>is</strong> variable, <strong>with</strong> an<br />
arbitrary lower limit of 30% and an arbitrary upper limit of 78%. <strong>The</strong> mean of the<br />
d<strong>is</strong>tribution was set at 60%.